Evidence map›Paper›PMID 28775716›Full record

ArticleFrontiers in microbiology2017

Characterization of Heterogeneous MRSA and MSSA with Reduced Susceptibility to Chlorhexidine in Kuwaiti Hospitals.

Leila Vali, Ali A Dashti, Febine Mathew, Edet E Udo

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Molecular epidemiology of methicillin-resistantFrontiers in microbiology · 2025
    Review
  3. Genomic profiling of methicillin-sensitiveFrontiers in microbiology · 2024
    Article
  4. Community-Acquired Methicillin-ResistantDiagnostics (Basel, Switzerland) · 2023
    Article
  5. Article
  6. A Sequalae of Lineage Divergence inDiagnostics (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Increasing usage of chlorhexidine in health care settings: blessing or curse? A narrative review of the risk of chlorhexidine resistance and the implications for infection prevention and control.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Review
  9. Article
  10. Article
  11. Reduced Susceptibility to Chlorhexidine amongAntibiotics (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Epidemiology of β-Lactamase-Producing Pathogens.Clinical microbiology reviews · 2020
    Review
  16. Article
  17. Povidone Iodine 0.66% to FightCase reports in ophthalmology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leila ValiDepartment of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Kuwait UniversitySulaibekhat, Kuwait.
Ali A DashtiDepartment of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Kuwait UniversitySulaibekhat, Kuwait.
Febine MathewDepartment of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Kuwait UniversitySulaibekhat, Kuwait.
Edet E UdoDepartment of Medical Microbiology, Faculty of Medicine, Kuwait UniversitySulaibekhat, Kuwait.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this investigation was to identify the lineages of MRSA and MSSA with reduced susceptibility to chlorhexidine in Kuwaiti hospitals. 121 clinical MRSA and 56 MSSA isolates were included in this study. Antimicrobial susceptibility testing was performed for a selection of agents including chlorhexidine and resistance genes were amplified and sequenced. PFGE, spa typing, and MLST were completed for a selection of isolates. The results showed SCC

Indexed as

chlorhexidineMLSTMRSAMSSAPFGEspa typing

Identifiers

PMID28775716
PMCPMC5517409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.